Federal Trade Commission May 4, 2007 – Federal Register Recent Federal Regulation Documents

Agency Information Collection Activities; Comment Request
Document Number: E7-8567
Type: Notice
Date: 2007-05-04
Agency: Federal Trade Commission, Agencies and Commissions
The FTC is considering conducting a study to analyze the use and likely short- and long-run competitive effects of authorized generic drugs in the prescription drug marketplace. Before investigating these issues, the FTC is seeking public comments on its proposed information requests to firms in the prescription drug industry. The information collection requirements described below will be submitted to the Office of Management and Budget (``OMB'') for review, as required by the Paperwork Reduction Act (``PRA'') (44 U.S.C. 3501-3520).
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.